| Literature DB >> 33109205 |
Ben Xu1, Yi-Ji Peng2, Guo-Zhong Ma3, Qian Zhang4.
Abstract
BACKGROUND: To introduce a novel "three-port" trocar placement technique for laparoscopic radical prostatectomy (LRP) in prostate cancer (PCa) patients.Entities:
Keywords: Laparoscopic; Radical prostatectomy; Three-port; Trocar
Mesh:
Year: 2020 PMID: 33109205 PMCID: PMC7592506 DOI: 10.1186/s12957-020-02051-y
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1Images of the external cavity. a With an assistant holding the laparoscope, the surgeon alone completed all procedures of the operation. b Only three trocars were placed, including one just in the umbilical region and two on the left/right lateral margin of the rectus abdominis muscle with a length of 2 finger-breadths below the umbilicus. c The total lengths of incisions were 1.5 + 0.5 + 0.5 = 2.5 cm for the prostate volume (evaluated by preoperative B-ultrasonography) ≤ 30 ml or 2.5 + 0.5 + 0.5 = 3.5 cm for the prostate volume > 30 ml
Patient demographics and outcome characteristics of patients among groups
| Variables | Group A | Group B | Group C | Group D | ||||
|---|---|---|---|---|---|---|---|---|
| A vs B | A vs C | A vs D | ||||||
| No. patients | 144 | 88 | 57 | 11 | – | – | – | – |
| Age (years) | 66.0 ± 7.1 | 67.7 ± 6.8 | 66.5 ± 6.3 | 68.6 ± 8.5 | 0.244 | – | – | – |
| BMI (kg/m2) | 24.2 ± 2.6 | 24.8 ± 2.9 | 24.6 ± 2.7 | 23.6 ± 2.9 | 0.253 | – | – | – |
| Smoking history (%) | 16 (11.1%) | 15 (17.0%) | 6 (10.7%) | 2 (18.2%) | 0.470 | – | – | – |
| ADT history (%) | 16 (11.1%) | 5 (5.7%) | 1 (1.8%) | 1 (9.1%) | 0.100 | – | – | – |
| PSA level (ng/ml) | 13.4 ± 12.1 | 15.2 ± 12.6 | 14.1 ± 27.3 | 15.2 ± 17.7 | 0.867 | – | – | – |
| Prostate volume (ml) | 35.2 ± 16.0 | 42.6 ± 26.7 | 46.7 ± 25.2 | 36.6 ± 11.5 | 0.003 | 0.118 | 0.013 | 0.999 |
| Preoperative Gleason scores by puncture (%) | ||||||||
| < 7 | 37 (25.7%) | 30 (34.1%) | 20 (35.1%) | 5 (45.4%) | 0.113 | – | – | – |
| = 7 | 88 (61.1%) | 38 (43.2%) | 28 (49.1%) | 4 (36.4%) | ||||
| > 7 | 19 (13.2%) | 20 (22.7%) | 9 (15.8%) | 2 (18.2%) | ||||
| EBL (ml) | 94.2 ± 73.4 | 216.7 ± 173.2 | 1247.9 ± 1137.2 | 150.0 ± 130.4 | < 0.001 | < 0.001 | < 0.001 | 0.661 |
| OT (min) | 113.8 ± 21.1 | 130.6 ± 30.3 | 240.1 ± 52.1 | 214.4 ± 38.8 | < 0.001 | 0.002 | < 0.001 | < 0.001 |
| Drainage days (days) | 4.0 ± 2.6 | 3.7 ± 2.9 | 6.4 ± 5.7 | 4.5 ± 1.6 | < 0.001 | 0.973 | 0.018 | 0.913 |
| Hospitalization days (days) | 5.1 ± 2.9 | 5.2 ± 3.4 | 8.8 ± 5.8 | 6.3 ± 2.5 | < 0.001 | 1.000 | < 0.001 | 0.647 |
| Transfusion (ml) | 0 | 4.5 ± 42.6 | 652.6 ± 789.8 | 0 | < 0.001 | 0.897 | < 0.001 | – |
| Complications | ||||||||
| 0 | 130 (96.3%) | 81 (92.0%) | 52 (91.2%) | 10 (90.9%) | 0.104 | – | – | – |
| I | 4 (3.0%) | 5 (5.7%) | 3 (5.3%) | 0 | ||||
| II | 1 (0.7%) | 0 | 2 (3.5%) | 1 (9.1%) | ||||
| III | 0 | 2 (2.3%) | 0 | 0 | ||||
| Postoperatively pathological stages (%) | ||||||||
| T2 | 87 (60.4%) | 41 (46.6%) | 34 (59.6%) | 5 (45.5%) | 0.161 | – | – | – |
| T3 | 57 (39.6%) | 47 (53.4%) | 23 (40.4%) | 6 (54.5%) | ||||
| PSM (%) | 40 (27.8%) | 27 (30.7%) | 19 (33.3%) | 4 (36.4%) | 0.792 | – | – | – |
| Postoperative Gleason scores by operation (%) | ||||||||
| < 7 | 10 (6.9%) | 9 (10.2%) | 8 (14.0%) | 1 (9.1%) | 0.242 | – | – | – |
| = 7 | 112 (77.8%) | 56 (63.6%) | 39 (68.4%) | 8 (72.7%) | ||||
| > 7 | 22 (15.3%) | 23 (26.1%) | 10 (17.6%) | 2 (18.2%) | ||||
Group A, three-port LRP; group B, conventional four-five-port LRP; group C, ORP; group D, RARP
No. number, BMI body mass index, PSA prostate-specific antigen, EBL estimated blood loss, OT operative time, PSM positive surgical margin
Fig. 2A comparison of three-port LRP between the early stage (initial 72 cases) and the late stage (next 72 cases) for the parameters of OT, EBL, drainage days, and hospitalization days
A synopsis of published series on the surgical treatment of PCa
| Reference | Treatment | No. of patients | OT (min) | EBL (ml) | Drainage days (days) | Hospitalization days (days) | Complications (%) | PSM (%) |
|---|---|---|---|---|---|---|---|---|
| Zhu et al. [ | Single-port LRP | 6 | 252.5 | 300 | 11 | NA | 33 | 0 |
| Zhang et al. [ | Two-port LRP | 15 | 170.1 | 100.7 | 5.7 | NA | 13.3 | 13.3 |
| İnkaya et al. [ | ORP | 128 | 160 | 1600 | NA | 9 | 81.25 | 33.04 |
| Yaxley et al. [ | ORP | 151 | 234.34 | 1338.14 | 8.42 | 3.27 | 10.6 | 8.0 |
| İnkaya et al. [ | Conventional LRP | 48 | 248 | 183 | 11.6 | 3.68 | 8.3 | 12.5 |
| Papachristos et al. [ | Conventional LRP | 100 | 195 | 300 | NA | 2 | 12 | 13 |
| Sirisopana et al. [ | Conventional LRP | 241 | 210 | 500 | NA | 6 | 29.05 | 40.63 |
| Johnson et al. [ | Conventional LRP | 544 | 213 | NA | 10.6 | 3.2 | 19.1 | 27.6 |
| Qi et al. [ | Conventional LRP | 74 | 143.8 | 316.89 | 4.77 | 7.09 | NA | 45.9 |
| Yaxley et al. [ | RARP | 157 | 222.03 | 443.74 | 8.21 | 1.55 | 4.5 | 11.0 |
| İnkaya et al. [ | RARP | 778 | 206 | 172 | 9.2 | 3.02 | 2.4 | 17.0 |
| Papachristos et al. [ | RARP | 100 | 195 | 300 | NA | 2 | 9 | 10 |
| Sirisopana et al. [ | RARP | 295 | 200 | 300 | NA | 6 | 8.81 | 39.15 |
| Johnson et al. [ | RARP | 1081 | 135 | NA | 13.3 | 2.9 | 16.4 | 22.5 |
| Tasci et al. [ | RARP | 1499 | 181.9 | 225.4 | 2.3 | 2.9 | 6.1 | 14.1 |
| Kaouk et al. [ | Single-port RARP | 10 | 197.5 | 143 | 8 | 0 | 0 | 50.0 |
| Dobbs et al. [ | Single-port RARP | 10 | 234 | 65 | 1.3 | 1.3 | 0 | 20.0 |
| Our series | Three-port LRP | 144 | 113.8 | 94.2 | 4.0 | 5.1 | 3.7 | 27.8 |
PCa prostate cancer, ORP open radical prostatectomy, LRP laparoscopic radical prostatectomy, RARP robotic-assisted radical prostatectomy, No. number, OT operative time, EBL estimated blood loss, PSM prostate surgical margin, NA not available